Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents

Joel Castro Kraftchenko, Sonia Garcia Caraballo, Jessica Maddern, Gudrun Schober, Amanda Lumsden, Andrea Harrington, Shirdi Schmiel, Beatriz Lindstrom, John Adams, Stuart Brierley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Publication statusE-pub ahead of print - 13 Apr 2021

Cite this